Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know

Zoetis (ZTS) gained 2.37% in the latest session, outperforming the S&P 500's 0.6% gain. However, the animal health company faces headwinds with forecasted EPS declining 10.59% and revenue expected to drop 3.66% in the upcoming quarter. The stock holds a Zacks Rank of #4 (Sell) with no recent estimate revisions, and trades at a Forward P/E of 11.78, below its industry average.